Mercer Island, WA, United States of America

R E Fournier

This inventor holds 1 USPTO granted patent. Top assignee: Fred Hutchinson Cancer Center. Active years: 1996.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 1996

Loading Chart...
1 patent (USPTO):Explore Patents

Title: R E Fournier: Innovator in Avian/Mammalian Microcell Hybrids

Introduction

R E Fournier is a notable inventor based in Mercer Island, WA (US). He has made significant contributions to the field of biotechnology, particularly in the development of avian/mammalian microcell hybrids. His innovative work has implications for genetic research and therapeutic applications.

Latest Patents

Fournier holds a patent for "Recombination-proficient avian/mammalian microcell hybrids." This patent describes an avian/mammalian microcell hybrid immortalized pre B cell line that contains a mammalian chromosome carrying a selectable marker. This hybrid cell line can be utilized for introducing predetermined point mutations into specific mammalian chromosomal loci through high-frequency homologous recombination. He has 1 patent to his name.

Career Highlights

Fournier is associated with the Fred Hutchinson Cancer Center, where he contributes to groundbreaking research in cancer and genetic engineering. His work at this prestigious institution underscores his commitment to advancing scientific knowledge and improving health outcomes.

Collaborations

Throughout his career, Fournier has collaborated with esteemed colleagues, including Elliot M Epner and Ellen S Dieken. These partnerships have fostered a collaborative environment that enhances research productivity and innovation.

Conclusion

R E Fournier's contributions to the field of biotechnology, particularly through his patent on avian/mammalian microcell hybrids, highlight his role as an innovator. His work continues to influence genetic research and therapeutic strategies.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…